Ledger.Open graph →
SEC Form D · filed August 7, 2019

Pharmazz, Inc

Offering
$3.0M
Sold
$2.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WILLOWBROOK, IL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Tadmor Shalon · Sonoma, CAExecAaron Block · New York, NYDirectorMetaProp Holdings LLC · New York, NYExecFrederic Mayerson · Cincinnati, OHExec · DirectorGeoff L. Tabachnick · New York, NYExecKorey Korfiatis · Wenatchee, WAExec · DirectorThomas L. Mcdougal · DALLAS, TXExecEric L. Langford · DALLAS, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗